BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, October 21, 2024
See today's BioWorld
Home
» Other news to note for May 26, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for May 26, 2021
May 26, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 9 Meters, Affyimmune, Altimmune, Anixa, Axim, Beyond, C4, Cellaria, Circassia, Clarus, Contrafect, Dyadic, Exacis, Gensight, Inhalon, Kymera, Lipocine, Merck, Mynd, Odyssey Group, Ontario, Ori, Progenity, Syngene, Vineti.
BioWorld
Briefs
Other news to note
Coronavirus